Oxidised LDL modulate adipogenesis in 3T3-L1 preadipocytes by affecting the balance between cell proliferation and differentiation  by Masella, Roberta et al.
FEBS Letters 580 (2006) 2421–2429Oxidised LDL modulate adipogenesis in 3T3-L1 preadipocytes
by aﬀecting the balance between cell proliferation and diﬀerentiation
Roberta Masellaa,*, Rosaria Varı`a, Massimo D’Archivioa, Carmela Santangeloa,
Beatrice Scazzocchioa, Maria Teresa Maggiorellab, Leonardo Sernicolab, Fausto Tittib,
Massimo Sanchezc, Umberto Di Mariod,1, Gaetano Letod, Claudio Giovanninia
a National Centre for Food Quality and Risk Assessment, Istituto Superiore di Sanita`, Viale Regina Elena 299, 00161 Rome, Italy
b National AIDS Centre, Istituto Superiore di Sanita`, Viale Regina Elena 299, 00161 Rome, Italy
c Department of Cell Biology and Neurosciences, Istituto Superiore di Sanita`, Viale Regina Elena 299, 00161 Rome, Italy
d Department of Clinical Sciences, Universita` ‘‘La Sapienza’’, 00161 Rome, Italy
Received 1 March 2006; revised 22 March 2006; accepted 23 March 2006
Available online 30 March 2006
Edited by Robert BaroukiAbstract The eﬀects of oxidised LDL (oxLDL) on cell prolifer-
ation, apoptosis and hormone-induced diﬀerentiation have been
evaluated for the ﬁrst time in 3T3-L1 preadipocytes. Unlike con-
trol cells, oxLDL-treated preadipocytes showed a high prolifer-
ation rate, a low apoptosis level, and an impaired diﬀerentiation
process with an increased preadipocyte factor-1 (Pref-1) mRNA
expression at late times. By silencing Pref-1 mRNA or inhibiting
its expression with an increased dexamethasone concentration,
diﬀerentiation occurred as usual, which demonstrates the key
role of Pref-1 overexpression. The results suggest a speciﬁc ac-
tion of oxLDL on the adipogenesis inhibitor Pref-1, as indicated
also by its reappearance in mature adipocytes treated with
oxLDL. The inhibitory eﬀects of oxLDL on diﬀerentiation re-
quired oxLDL uptake by CD36, and were associated with lipo-
protein lipids. These results point to oxLDL as a modulator of
adipose tissue mass and as possible link between obesity and
its clinical complications.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Preadipocyte factor-1; CD361. Introduction
Oxidised low density lipoproteins (oxLDL) have been found
in arteriosclerosis, type 2 diabetes and recently in the plasma of
obese patients [1–3]. OxLDL modulate growth and transcrip-
tion factors and cytokine production, inﬂuencing cell prolifer-
ation, apoptosis and diﬀerentiation [4–7]. These eﬀects areAbbreviations: PPAR, peroxisome proliferator-activated receptor;
Pref-1, preadipocyte factor-1; aP2, adipocyte fatty acid binding
protein; PS, phosphatidylserine; DMIX, diﬀerentiation mixture; STS,
staurosporine; DHE, dihydroetidium; DHR 123, dihydrorhodamine
123; DiI, 1,1 0-Dioctadecyl-3,3,30,30-tetramethylindo carbocyanine
perchlorate; siRNA, synthetic short interfering RNA; LipE, lipid
extracts from oxLDL
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doi:10.1016/j.febslet.2006.03.068mediated by the binding with several classes of scavenger
receptors, among which CD36, also expressed by adipocytes
[8].
The highly dynamic adipose tissue has important endocrine
and, possibly, immunological roles, apart from its traditional
function as energy storage depot [9]. Adipocytes respond to
hormonal messages and, in turn, release hormones and cyto-
kines as a function of the adipose mass [10]. Various factors
may govern the equilibrium between proliferation, apoptosis
and diﬀerentiation processes to maintain the homeostasis of
adipose tissue [11]. In particular, the recruitment of new adi-
pose cells is made possible by the presence of preadipocytes,
which, under appropriate stimuli, are capable of diﬀerentiating
into cells exhibiting the biochemical and metabolic features of
mature adipocytes. Several transcriptional factors, acting in
temporal sequence, have been identiﬁed as potential regulators
of adipocyte diﬀerentiation [12]. Key among these factors is
peroxisome proliferator-activated receptor-c (PPARc) [13–16].
Conversely, Pref-1 is highly expressed in preadipocyte cell
membranes, but is not detectable in mature fat cells. When
cleaved to generate soluble form, it is an active inhibitor of adi-
pocyte diﬀerentiation [17,18]. Downregulation of Pref-1 is re-
quired for adipose conversion and expression of nuclear
factors stimulating diﬀerentiation such as PPARc [19].
The aim of the study was to evaluate the eﬀects of oxLDL on
the balance between proliferation and diﬀerentiation activity
to understand their role in adipose tissue homeostasis.
To this purpose, we investigated in 3T3-L1 cell line: (i) the
eﬀects of oxLDL on cell proliferation and apoptosis in
preconﬂuent preadipocytes; and (ii) the role of oxLDL and
their lipid components in hormone-induced adipocyte
diﬀerentiation.2. Materials and methods
2.1. Cell culture and diﬀerentiation
Murine 3T3-L1 preadipocytes (American Cell Culture Collection)
were cultured in DMEM (Hyclone, Cramlington, UK) supplemented
with 10% foetal calf serum (Flow Laboratories, Irvine, UK). At conﬂu-
ence (day 0) the cells were treated with the diﬀerentiation mixture
(DMIX) containing 1 lM insulin, 0.25 lM dexamethasone and 0.5
nM isobuthylmetylxantine for 48 h. The medium was changed, and
1 lM insulin added for 48 h. Then the cells were cultured in DMEM
until day 7.blished by Elsevier B.V. All rights reserved.
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Cells were ﬁxed for 1 h at room temperature with 10% formalin in
PBS, and then stained as described elsewhere [20]. The cells were exam-
ined under an optical microscope (Nikon Corporation, Tokyo, Japan).
2.3. Plasma LDL isolation, oxidation and lipid extraction
LDL (1.019–1.063 g/ml) were isolated from pooled fresh plasma of
healthy volunteers by density gradient ultracentrifugation in vertical
rotor as previously described elsewhere [21]. The protein content was
measured by Lowry’s method using BSA as standard [22]. Native
LDL (nLDL) were oxidised with 20 lM CuSO4 for 18 h at 37 C. Oxi-
dation was stopped by 1 mM EDTA. The degree of LDL oxidation
was checked by determining the TBARS content according to Yagi
[23]; the TBARS content of oxLDL was 45 ± 7 nmol malondialdehyde
equivalent/mg LDL protein. The relative electrophoretic mobility was
1.9 ± 0.2.
OxLDL were sterilised by a 0.22 lm membrane (Millipore Corpora-
tion, Bedford, MA) and incubated with cells. We tested diﬀerent LDL
concentrations (25–200 mg protein/l) and chose 50 mg protein/l be-
cause of the complete absence of cytotoxicity as assessed by the Neu-
tral Red assay. Lipids were extracted from native and oxLDL (nLipE
and LipE, respectively) according to Folch et al. [24]. The organic
phase was dried under nitrogen and the content of extracts was deter-
mined by microgravimetry. The lipid residue was dissolved in ethanol
and added to the culture medium (equivalent to 50 mg LDL protein/l
culture medium). For all the experimental conditions described below,
we used 3T3-L1 cells untreated or treated with nLDL (0.5 mg/l) and
nLipE as controls. As we obtained wholly overlapping results, Section
3 reports the data that refer only to untreated cells.
2.4. Uptake of oxLDL
Measurements of oxLDL uptake by preadipocytes at conﬂuence
were accomplished with ﬂuorescence labelled lipoproteins. One millili-
tre of LDL (0.5 g/l) was incubated with 12 ll 1,1 0-Dioctadecyl-
3,3,3 0,3 0-tetramethylindo-carbocyanine perchlorate (DiI) (2 mg/ml
DMSO) (Sigma, St Louis, MO, USA) and 10 lM CuSO4 for 3 h as
previously described [25]. Labelled oxLDL were extensively dialysed
with a centrifugal ﬁlter device (Millipore, Bedford, MA) with a molec-
ular weight cut-oﬀ of 5000 at 4 C, and sterilized through 0.22 lm
ﬁlters (Millipore Bedford, MA). Relative electrophoretic mobility of
DiI-labelled oxLDL was 1.8 ± 0.1. DiI-oxLDL (0.05 mg/ml of culture
medium) were incubated with the preadipocytes (0,5 · 106 cells) for
2 h. Cells were resuspended in PBS containing propidium iodide (PI)
to exclude dead cells, and then kept on ice before measuring ﬂuores-
cence levels with Epics Elite ESP Flow-Cytometer (Beckman Coulter,
Miami, FL, USA). Fluorescence levels were normalised to preadipo-
cytes autoﬂuorescence. The amount of uptake was corrected on the ba-
sis of cell number. For the binding assay, the preadipocytes were
incubated with 10–100 mg/l DiI-oxLDL at 4 C for 2 h. Non-speciﬁc
binding was measured in the presence of 20-fold excess of unlabelled
oxLDL and subtracted from the total binding to estimate speciﬁc bind-
ing. For inhibition assays, cells were incubated for 2 h with 0–20 mg/l
mouse IgA anti-mouse CD36 monoclonal antibody (clone 63) (Chem-
icon International, Temecula, CA,USA) blocking oxLDL uptake, and
then treated with ﬂuorescent oxLDL (0.05 mg/ml) at 37 C for 2 h. The
same experiments were performed using mouse IgA of irrelevant spec-
iﬁcity as control.
2.5. Determination of cell proliferation and apoptosis induction
3T3-L1 cells were seeded in 6-well plates containing DMEM plus 2%
Ultroser G. Seventy ﬁve percent conﬂuent cell cultures were exposed to
50 mg/l oxLDL and, after incubation (24 h), screened for proliferation
activity and apoptosis. Proliferation activity was evaluated by [14C]thy-
midine incorporation (Amersham, Buckinghamshire, UK; speciﬁc
activity 2.09 GBq/mmol) as previously described [26]. Thymidine
incorporation was expressed as a percentage of values observed in un-
treated controls.
Apoptotic adherent cells were evaluated with the ApoAlert Annexin
V apoptosis Kit (Clontech Laboratories, Palo Alto, CA, USA) follow-
ing the manufacturer’s instructions. Two-color cytometric analysis
(Fluorescence-Activated Cell Sorting, FACS) was performed on a
Coulter Epics Elite ESP cell Sorter (Miami, FL, USA) with an ar-
gon-ion laser tuned at 488 nm. Cells treated with 1 lM staurosporine
(STS) were used as positive controls.2.6. Intracellular reactive oxygen species (ROS)
Intracellular concentrations of O2 and H2O2 were evaluated by incu-
bating the cells (5 · 105) with 5 lL dihydroetidium (DHE) and dihy-
drorhodamine 123 (DHR 123), respectively, as previously described
[26]. To exclude PI-positive cells from the analysis of H2O2 production,
we performed a double staining procedure by using DHR 123/PI to
estimate the percentage of dead cells. In samples stained with DHE
(which emits in the FL2 channel like PI does) we incubated parallel
tubes with PI for 15 min at 37 C.
2.7. Eﬀects of oxLDL and lipid extract (LipE) on diﬀerentiation
OxLDL (50 mg of protein/l) were added to the cells at conﬂuence to-
gether with DMIX, and maintained in the medium throughout the
experiment. Cells treated with DMIX were used as control. Total
RNA was isolated to study the expression of selected genes involved
in diﬀerentiation, and lipid storage was monitored by Oil-Red O stain-
ing. In addition, nuclear proteins were extracted and analysed by Wes-
tern Blot. The same experiments were carried out incubating the cells
with the LipE from oxLDL (equivalent to 50 mg LDL protein/l of cul-
ture medium).
2.8. Total RNA extraction and RT-PCR analysis
Total RNA was isolated from 3T3-L1 with the TRIZOL reagent
(Invitrogen-Life technologies, USA) according to manufacturer’s rec-
ommendations. First-strand cDNA was generated from 1 lg of total
RNA using reverse transcription polymerase chain reaction (RT-
PCR) analysis (Invitrogen). The reverse transcription was performed
at 42 C for 50 min. Quantitative real-time PCR (RT q-PCR) was per-
formed with gene speciﬁc TaqMan MGB probes and primers (Applied
Biosystems) in an ABI 7700 sequence detector (Applied Biosystems).
Pref-1 (Accession No. NM_010052) and endogenous control TBP
(TATA-box binding protein, Accession No. NM_013684) were pur-
chased as pre-designed assays (Pref-1: Mn00494477_m1), (TBP:
Mn00446973_m1) from Applied Biosystems. Probes and primers for
PPARc gene expression were also designed by and purchased from
Applied Biosystems (Assays-by-design Service for gene expression).
All primers pairs lie on diﬀerent exons, thus DNAse treatment was
not necessary. All gene expression assays have a FAM reporter dye
at 5 0 end of TaqMan MGB probe and a non-ﬂuorescent quencher at
the 3 0 end of the probe.
Expression of Pref-1 and PPARc genes was determined as the
amount of Pref-1 and PPARc mRNA relative to mRNA for TBP by
using the comparative CT method described in the ABI 7700 sequence
detection system, user bulletin #2.
For semiquantitative RT-PCR the primer sequences used were as
follows. Pref-1: sense, 5 0-gcgccaacaatggaacttgcgt-3 0; antisense, 5 0-gag-
gggtactcttgttgagctc-3 0; adipocyte fatty acid binding protein (aP2):
sense, 5 0-atgtgtgatgcctttgtggga-30; antisense, 5 0-tgccctttcataaactcttgt-
3 0; CD36: sense 5 0-tcggaactgtgggctcattg-3 0; antisense 5 0-
cctcggggtcctgagttatattttc-30. The reaction conditions were: denatur-
ation 94 C for 1 min, annealing 58 C (aP2 and CD36) or 62 C
(Pref-1) for 1 min, and extension 72 C for 2 min. Ampliﬁcation was
done in an automated heat-block (Minicycler, MJ Research). PCR
products, electrophoresed on 1.5% agarose gel, were visualised by ethi-
dium bromide staining. The relative level of RT-PCR reaction was
measured with a molecular imager FX (Biorad Laboratories, Inc., Her-
cules, CA, USA) and quantiﬁed with respect to GAPDH.
2.9. Western Blot analysis
For immunoblotting determination of PPARc, nuclear protein ex-
tracts were prepared by Nuclear/Cytosol fractionation Kit (Medical
& Biological Laboratories, Watertown, LA, USA) according to the
manufacturer’s instructions. For CD36 analysis, whole cell extracts
from 3T3-L1 were prepared: cells were collected and washed twice in
ice-cold PBS, resuspended in 50 ll Triton X 1% (Sigma) with 5 ll of
a mixture of protease inhibitors (Sigma), and incubated on ice for
20 min. Cells were centrifuged at 18000 · g for 10 min at 4 C. Super-
natants were used for Western Blot analysis.
Protein concentrations were determined by Lowry’s method [22].
Thirty micrograms of sample protein was separated by 12% SDS–
PAGE and transferred to a nitrocellulose membrane. Membranes,
blocked with PBS containing 5% dry milk and 0.1% Tween 20, were
treated with antibodies that recognise PPARc or CD36 (Santa Cruz,
Biotechnology Inc, CA, USA). The blots were treated with appropriate
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Cruz Biotechnology) followed by ECL detection (Amersham Bio-sci-
ences, UK). Densitometric analysis was performed with a molecular
imager FX (Biorad, Hercules CA). Equal loading of proteins was ver-
iﬁed by GAPDH immunoblotting with a goat anti-GAPDH antibody
(Santa Cruz Biotechnology).
2.10. SiRNA transfection
Synthetic short interfering RNA (siRNA) against murine Pref-1 was
provided in the duplex-ready stable 2 0-ACE protect form. (Dharma-
con, Lafayette, CO, USA). The sense and anti-sense strands of siRNA,
beginning at nt 549 (Accession No. L12721), were 5 0-GAUCAAUGG-
UUCUCCCUGCdTdT-3 0 and 3 0-dTdTCUAGUU-ACCAAGAGG-
GACG-5 0, respectively. The sequence 5 0-AATCAACGGTTATC-
CATGC-3 0 was used as the scrambled siRNA control; it does not
match any mammalian sequences currently available in online dat-
abases. Before use, siRNA was deprotected and reconstituted in buﬀer
according to the manufacturer’s instructions. siRNA solution (10 nM)
and Lipofectamine 2000 (Invitrogen Life Technologie, USA) (1 lg/lL)
were diluted in Opti-MEM I medium (Invitrogen), incubated for
20 min at room temperature to allow siRNA:Lipofectamine complexes
formation according to the manufacturer’s instructions.
Pre-conﬂuent 3T3-L1 preadipocytes were incubated with anti-Pref-1
siRNA:lipofectamine complexes, under serum-free conditions, at 37 C
for 24 h before the addition of DMIX and oxLDL. Pref-1 levels were
monitored by RT q-PCR.2.11. Eﬀect of anti-murine CD36 on diﬀerentiation
Cells were incubated with 10 mg/l of mouse anti-mouse CD36 mono-
clonal blocking antibody (IgA, clone 63) (Chemicon International,
Temecula, CA,USA) for 18 h before the addition of DMIX and
oxLDL; the antibody was replaced every time the medium was chan-
ged, until the end of the experiment. Cells induced to diﬀerentiate,
without oxLDL, in the presence of anti-CD36 were used as further
control.Fig. 1. Eﬀects of oxLDL on preadipocyte cell proliferation, apoptosis and
Percentage of apoptotic Annexin V-positive cells in preconﬂuent 3T3-L1 ce
compared with untreated control cells (CTR). Cells treated with 1 lM STS
determination of hydrogen peroxide and superoxide anion respectively after
median values of the ﬂuorescence intensity histograms after conversion of lo
expressed as means ± S.E.M. of four independent experiments. *P < 0.01 vs.2.12. Statistical analysis
Results are expressed as means ± S.E.M. of at least three experi-
ments performed in duplicate. The comparison between two groups
was performed by Student’s t-test. ANOVA plus the Bonferroni cor-
rection were used when more than two groups were compared. Diﬀer-
ences were considered signiﬁcant when P P 0.05.3. Results
3.1. Eﬀect of oxLDL on proliferation and apoptosis induction
We evaluated subcellular activity of oxLDL by studying
their eﬀect on cell proliferation and apoptosis in pre-conﬂuent
3T3-L1. We observed that a 24-h treatment with 50 mg/l
oxLDL caused a signiﬁcant increase in [14C]thymidine incor-
poration with respect to control cells (P < 0.01) (Fig. 1A).
Under the same experimental conditions, apoptosis analysis
indicated a signiﬁcant decrease in apoptotic cells after 24 h of
oxLDL exposure with respect to control cells (P < 0.01)
(Fig. 1B). The results obtained treating the cells with 1 lM
staurosporine, the proapoptotic agent we used as positive con-
trol, demonstrated that the apoptotic pathway is functionally
active.
3.2. Evaluation of ROS production
To understand whether oxLDL induced intracellular redox
imbalance, time-course experiments evaluating intracellular
ROS production were carried out in pre-conﬂuent cultures.
The intracellular production of O2 and H2O2 did not show
any diﬀerence between cell cultures treated with oxLDL and
control cells (Fig. 1C and D).ROS content. (A) Relative incorporation of [14C]thymidine and (B)
lls exposed to 50 mg/l oxidised LDL (oxLDL) after 24 h treatment as
were used as apoptosis positive control. (C) and (D) Cytoﬂuorimetric
6, 12 and 24 h incubation of cells with oxLDL (50 mg/l). Data are the
garithmically ampliﬁed signals into values on a linear scale. Values are
CTR.
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The eﬀects of oxLDL and LipE on adipogenesis were stud-
ied in conﬂuent preadipocytes induced to diﬀerentiate by
DMIX. Microscopy analysis using Oil Red O staining dem-
onstrated a marked decrease in lipid storage on day 7 in
oxLDL- and LipE-treated cells with respect to control cells
(Fig. 2A), indicating a diﬀerentiation delay under these
experimental conditions. The delayed diﬀerentiation was also
conﬁrmed by mRNA expression of aP2 and PPARc, markers
of adipocyte diﬀerentiation. Ap2 was expressed at very low
levels on day 7 in treated cells (Fig. 2B). In addition, in
oxLDL- and LipE-treated cells, PPARc, evaluated by quan-
titative real time RT-PCR, did not show the marked increase
during diﬀerentiation observed in control cells (P P 0,05)
(Fig. 2C). Furthermore, oxLDL-associated attenuation of
PPARc gene expression was accompanied by a signiﬁcant de-
crease (P < 0.01) in the nuclear PPARc protein evaluated on
day 7 in oxLDL-treated cells with respect to controls
(Fig. 2D).Fig. 2. Eﬀect of oxLDL and lipid extract from oxLDL (LipE) on hormone-in
extract from oxLDL equivalent to 50 mg oxLDL protein/l of culture medium
by DMIX (1 lM insulin, 0.25 lM dexamethasone and 0.5 nM isobuthylmety
period (0–7 days). (A) Intracellular lipid storage evaluated by microscopy ana
(B) Representative blots (n = 4) of semiquantitative RT-PCR evaluation
diﬀerentiation. GAPDH was the reference gene. (C) Quantitative real-time
period. Values represent the means ± S.E.M. of three independent experimen
PPARc protein expression performed on days 0 and 7 by Western blottin
isoforms, c1 and c2. The blots are representative of three independent
immunoblotting. CTR: diﬀerentiating control cells. oxLDL: oxLDL-treated3.4. Pref-1 expression
To determine whether reduced lipid storage and diﬀerentia-
tion delay resulted from an oxLDL-induced alteration in the
diﬀerentiation program, the expression of the inhibitory Pref-
1 was quantitatively evaluated. OxLDL exerted relevant eﬀects
on Pref-1 expression. The decrease observed in diﬀerentiating
control cells was prevented in oxLDL- and LipE-treated cells,
which showed a higher level of Pref-1 mRNA with respect to
the controls, especially on day 7 (P < 0,01) (Fig. 3A).
To evaluate whether oxLDL could have a speciﬁc eﬀect on
Pref-1 expression,mature adipocytes (15days afterDMIX treat-
ment), no longer expressing the inhibitory factor, were incu-
bated with nLDL and oxLDL for 4 h. After this treatment the
cells treated with oxLDL expressed Pref-1 gene again (Fig. 3B).
3.5. Role of Pref-1 in oxLDL-induced diﬀerentiation delay
To test the hypothesis that Pref-1 could play a pivotal role in
the oxLDL-mediated inhibition of the diﬀerentiation process
in 3T3-L1 cells, we followed two diﬀerent approaches.duced adipogenesis in 3T3-L1 cells. Fifty mg oxLDL protein/l or lipid
, were added to conﬂuent preadipocytes (day 0), induced to diﬀerentiate
lxantine), and maintained in the medium throughout the experimental
lysis with Oil Red O staining on day 7 after induction of diﬀerentiation.
of aP2 mRNA throughout the 7-day period after induction of
PCR determination of PPARc mRNA throughout the diﬀerentiation
ts. *P < 0,05 vs control within each time point considered. (D) Nuclear
g and densitometric analyses. The antibody recognized both PPARc
experiments. Equal loading of proteins was veriﬁed by GAPDH
diﬀerentiating cells. LipE: LipE-treated diﬀerentiating cells.
Fig. 3. Expression of Pref-1 mRNA in 3T3-L1 cells treated with
oxLDL or lipid extract from oxLDL. (A) Quantitative real-time PCR
evaluation of Pref-1 mRNA during the diﬀerentiation period (0–7
days) in preadipocytes treated with 50 mg oxLDL protein/l or lipid
extract from oxLDL equivalent to 50 mg oxLDL protein/l of culture
medium. At each time point, values represent the means ± S.E.M. of
three independent experiments. *P < 0.01 vs control within each time
point considered. (B) Semiquantitative RT-PCR evaluation of Pref-1
expression in mature adipocytes treated with native LDL (nLDL) or
oxLDL. On day 15 after induction of diﬀerentiation, 3T3-L1 cells were
exposed to 50 mg protein/l oxLDL or nLDL for 4 h. A representative
blot of three independent experiments is shown. GAPDH was the
reference gene. CTR: diﬀerentiating control cells. oxLDL: oxLDL-
treated cells. LipE: LipE-treated cells. nLDL: native LDL-treated cells.
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short interfering RNA against Pref-1 (siPref-1). Transfection
of untreated preadypocytes with anti-Pref-1 siRNA, but not
scrambled siRNA, caused about 90% reduction of Pref-1
mRNA expression 48 h after transfection, as detected by
RTq-PCR (data not shown). Transfection of diﬀerentiating
oxLDL-treated cells with anti-Pref-1 siRNA, but not scram-
bled siRNA, reverted the ability of ox-LDL to inhibit diﬀeren-
tiation process by downregulating Pref-1 mRNA expression on
days 2 and 7 (76% and 66%, respectively) (Fig. 4A).
The second approach was based on literature data which
have shown the central role of dexamethasone in downregulat-
ing Pref-1 expression, and a strong correlation between the
dose response of Pref-1 repression and the eﬀective concentra-
tion of dexamethasone [19]. Since in our experimental system
oxLDL-treated cells had Pref-1 mRNA levels signiﬁcantly
higher than controls, we tested the eﬀects of 1 lM dexametha-
sone instead of 0.25 lM, to assess whether it was possible to
neutralise the overexpression of Pref-1. Results showed that,
on day 7, 1 lM dexamethasone prevented the oxLDL-induced
increase in Pref-1 mRNA (56%) (Fig. 4B) with respect to
0.25 lM dexamethasone.
Likely as a consequence of the Pref-1 mRNA decrease we
obtained with the two approaches, the diﬀerentiation process
ran normally, as demonstrated by the increased PPARc levels
on days 2 and 7 (Fig. 4C and D) and by the storage of triglyc-
erides on day 7 (Fig. 4E).
Diﬀerentiating cells treated with 1 lM dexamethasone or
Pref-1 siRNA, in the absence of oxLDL, were comparable to
control cells (data not shown).3.6. CD36-mediated uptake of oxLDL and anti-murine CD36
monoclonal antibody eﬀects on 3T3-L1 diﬀerentiation
The increased mean ﬂuorescence intensity (2.4-fold) of DiI-
oxLDL treated cells with respect to controls demonstrated the
incorporation of DiI-oxLDL into preadipocytes at conﬂuence
(Fig. 5A). The speciﬁc binding between DiI-oxLDL and pre-
adipocytes exhibited a dose-dependent saturation pattern
(Fig. 5B). The total binding of DiI-oxLDL to preadipocytes
was eﬀectively inhibited by an excess amount of unlabelled
oxLDL.
To study whether oxLDL uptake in 3T3-L1 preadipocytes
could be mediated by CD36, ﬁrst we demonstrated that this
receptor was expressed, at RNA and protein levels, in conﬂuent
preadipocytes, although at a low level, and in diﬀerentiating
cells (Fig. 5C). To assess the relative contribution of CD36 to
preadipocyte-association of DiI-oxLDL, we studied the eﬀects
of anti-CD36 monoclonal antibody (clone 63) on the binding.
The cellular binding of DiI-oxLDL was inhibited in a dose-
dependent manner, and the inhibition level reached 53% of con-
trols with 10 lg/ml of antibody (5D). These results suggested
that CD36 had a major role in the binding of oxLDL by
3T3-L1 preadipocytes. Finally, to evaluate whether
CD36-mediated binding was involved in oxLDL-induced
diﬀerentiation delay, 3T3-L1 cells were pre-incubated with an
anti-CD36 monoclonal antibody for 18 h, then induced to dif-
ferentiate with DMIX and oxLDL. By inhibiting CD36-medi-
ated oxLDL uptake, Pref-1 expression decreased during
adipogenesis, while PPARc expression simultaneously in-
creased, allowing the diﬀerentiation process (Fig. 6A and B).
This clearly demonstrated that oxLDL needed to be taken up
by the scavenger receptor to exert their inhibitory eﬀects on adi-
pogenesis.4. Discussion
Adipose tissue mass reﬂects the number and average volume
of adipocytes, in particular the balance between cell acquisi-
tion and cell loss [27]. Changes in adipose tissue mass are asso-
ciated with changes in endocrine and metabolic functions of
adipose tissue that link increased or decreased adiposity to
alterations in systemic physiology [28,29].
Recently, the association has been demonstrated between
metabolic syndrome and high levels of circulating oxLDL [30].
With this in mind we evaluated the eﬀects of oxLDL on pro-
liferation, apoptosis and diﬀerentiation in 3T3-L1 murine pre-
adipocytes.
Firstly we showed that, in preconﬂuent cell cultures, oxLDL
induced high proliferation activity and a low rate of apoptotic
death with respect to untreated cells. OxLDL generally induce
progressive alterations of cell morphology leading to either
apoptosis or necrosis in several cultured cells [31,32]. The role
of ROS in oxLDL-mediated cytotoxicity has been recently re-
ported, in particular through the activation of the caspase cas-
cade [26,33] and the depletion of glutathione and its related
enzymes [21]. Under our experimental conditions, the absence
of oxLDL-mediated cytotoxicity was conﬁrmed by the fact
that no intracellular ROS was produced.
The results hereby presented provide evidence that, under
these experimental conditions, oxLDL exerted no cytostatic
or cytotoxic eﬀects, but contributed to maintain an undiﬀeren-
tiated behaviour in cells normally committed to acquiring a
Fig. 4. Eﬀects of anti-Pref-1 siRNA transfection or 1 lM dexamethasone treatment on oxLDL-induced diﬀerentiation delay. Quantitative real time
PCR determination of Pref-1 mRNA during the diﬀerentiation of oxLDL (50 mg/l)-treated preadipocytes (A) transfected with synthetic short
interfering RNA (siRNA) against murine Pref-1 or (B) induced to diﬀerentiate with hormonal-mixture containing dexamethasone 1 lM instead of
0.25 lM. Transfection of oxLDL-treated cells with scrambled siRNA was used as negative control. Quantitative real-time PCR determination of
PPARc in oxLDL-treated cells, transfected with anti-Pref-1 siRNA (C), or treated with 1 lM dexamethasone (D), as described above. Bars at each
time point represent the means ± S.E.M. of three independent experiments. *P < 0.01 vs oxLDL within each time point considered. (E) Intracellular
lipid storage evaluated by microscopy analysis with Oil Red O staining on day 7 after induction of diﬀerentiation. OxLDL: oxLDL-treated
diﬀerentiating cells. OxLDL + Si: OxLDL-treated cells transfected with anti-Pref-1 siRNA. OxLDL + dexa 1 lM: oxLDL-treated cells induced to
diﬀerentiate by DMIX containing 1 lM dexamethasone.
2426 R. Masella et al. / FEBS Letters 580 (2006) 2421–2429diﬀerentiated phenotype. As a matter of fact, we showed that
oxLDL, and in particular their lipid components, delayed
3T3-L1 preadipocytes diﬀerentiation, as shown by reduced
Oil Red staining, PPARc and aP2 expressions, likely by inter-
fering with the normal sequence of events that lead to the
appearance of diﬀerentiated adipocytes. Diﬀerentiation of adi-
pocytes involves changes in the expression of several proteins
[34] and genes tightly regulated by a balance between inhibi-
tory and promoting factors [35].
One of the main factors inhibiting adipocyte diﬀerentia-
tion is Pref-1 – member of the EGF-repeat domain-contain-
ing family of proteins – that regulates proliferation, growth
inhibition and diﬀerentiation, i.e. the fate of the cells. Some
evidence suggests that its disappearance would represent the
hallmark of the ‘‘commitment’’ of preadipocytes towards
adipogenesis. Pref-1 is highly expressed in preadipocytes,but completely abolished in adipose mature cells, thus
allowing the expression of diﬀerentiation-promoting factors
[36].
We demonstrated that, in 3T3-L1 cells treated with oxLDL,
Pref-1 did not show the expected time-dependent decrease
when DMIX was added. These ﬁndings, in light of Pref-1
inhibitory action on PPARc gene transcription, can explain
the consequent inhibition of diﬀerentiation observed in
oxLDL-treated cells, although it must be considered that sev-
eral pathways may be involved in the regulation of the diﬀer-
entiation process.
In this study Pref-1 seems to be the principal actor in the
oxLDL-induced alteration of the diﬀerentiation process. In-
deed, by knockdowning its mRNA, we prevented the
impairment of adipogenesis resulting from the increased
transcription of Pref-1.
Fig. 6. Eﬀects of anti-CD36 monoclonal antibody on oxLDL-induced diﬀerentiation delay in 3T3-L1 cells. Conﬂuent preadipocytes were pre-
incubated with an anti-CD36 monoclonal antibody (10 mg/l) for 18 h before treatment with DMIX and oxLDL. Quantitative real-time PCR analyses
were performed to evaluate Pref-1 (A) and PPARc (B) expressions at days 2 and 7 of diﬀerentiation. Bars at each time point represent the
means ± S.E.M. of three independent experiments. *P < 0.01 vs oxLDL, within each time point considered. OxLDL: oxLDL-treated diﬀerentiating
cells; oxLDL + abCD36: oxLDL-treated cells pre-incubated with antiCD36 monoclonal blocking antibody.
Fig. 5. Uptake of oxLDL in 3T3-L1 preadipocytes. (A) Cytoﬂuorimetric analysis of conﬂuent preadipocytes, treated for 2 h with oxLDL labelled
with 1,1 0-Dioctadecyl-3,3,3 0,3 0-tetramethylindo carbocyanine perchlorate (DiI) (full line) compared with control cells (dotted line). The ﬁgure is
representative of three independent experiments which provided similar results. (B) Binding assay of DiI-oxLDL by 3T3-L1 preadipocytes. Cells were
incubated at 4 C for 2 h with various concentrations of DiI-oxLDL (10–100 mg/l) in the absence (open circle) or presence (ﬁlled square) of 20-fold
excess of unlabelled oxLDL. Speciﬁc binding (ﬁlled circle) was determined by subtracting non-speciﬁc binding from total binding. (C) CD36
expression, as mRNA and protein, was evaluated in preadipocytes and diﬀerentiating cells by RT-PCR and Western blotting, respectively. The
analyses were performed in conﬂuent preadipocytes from day 0 to day 7 after the treatment with DMIX. Representative blots from four independent
experiments are shown. GAPDH was the reference for gene and protein evaluations. (D) Eﬀect of anti-CD36 monoclonal antibody on the uptake of
DiI-oxLDL. Conﬂuent preadipocytes were incubated at 37 C for 2 h with diﬀerent concentrations (0–20 mg/l) of mouse IgA anti-mouse CD36
blocking antibody (ﬁlled circle) or mouse IgA of irrelevant speciﬁcity (open circle), and then incubated with DiI-oxLDL (0.05 mg/ml of culture
medium) at 37 C for 2 h.
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conceivable that oxLDL exerted a speciﬁc eﬀect on Pref-1 gene,
as the reappearance of the message for the inhibitory factor in
mature adipocytes suggests. On the other hand oxLDL mightinterfere with the normal downregulating activity of dexameth-
asone, which normally reduces Pref-1 gene transcription [19].
We showed that a pronounced increment of dexamethasone
in DMIX oﬀset oxLDL-induced Pref-1 overexpression and
2428 R. Masella et al. / FEBS Letters 580 (2006) 2421–2429the consequent inhibition of diﬀerentiation, as shown by the in-
crease in PPARc and triglyceride storage.
OxLDL eﬀects on 3T3-L1 cells diﬀerentiation were associ-
ated with the lipid component of lipoproteins. As a point of
fact, lipid extracts of oxLDL showed the same behaviour as in-
tact particles, suggesting the involvement of oxidised lipids in
regulating gene expression as reported in the literature [37].
To exert their eﬀects, oxLDL generally need to be interna-
lised by scavenger receptors, among which CD36 was demon-
strated to play a central role. CD36 is present on mature
adipocytes and is able to recognise and bind oxLDL [38].
We demonstrated that oxLDL were taken up also by conﬂuent
preadipocytes through a speciﬁc, saturable, process, and that
CD36 played a major role in preadipocyte binding of oxLDL,
as shown by the dose-dependent inhibition of oxLDL binding
in cells treated with the anti-murine CD36 monoclonal anti-
body. Thus the inhibition of preadipocyte diﬀerentiation could
be related to CD36-mediated oxLDL uptake. The restored dif-
ferentiation process in diﬀerentiating 3T3-L1 cells treated with
oxLDL in the presence of anti-CD36 antibody conﬁrms this
hypothesis.
Altogether the results herein reported clearly suggest for the
ﬁrst time that oxLDL, internalised by CD36, inhibit preadipo-
cyte diﬀerentiation by increasing the expression of Pref-1 gene,
probably by interfering with dexamethasone activity.
By increasing cell proliferation, lowering apoptotic rate and
delaying the diﬀerentiation process, oxLDL might aﬀect the
number and size of the preadipocyte pool and inﬂuence adi-
pose tissue homeostasis. We could thus hypothesise that
oxLDL can contribute to the development of obesity and to
the appearance of insulin-resistance by reducing the mass of
insulin-sensitive adipose tissue.
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